In Other News

• New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

• New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

• Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

• Single Genetic Analysis Identifies Causes of Premature Ovarian Insufficiency

• Gut “Memory” May Explain Why IBD Flares Return

• New Automation Platform Standardizes DNA and RNA Extraction Across Clinical Workflows

• Bacterial Vesicle Expression System Streamlines Production of Cancer Diagnostic Proteins

• Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

• New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

• Multiprotein Plasma Panel Identifies Remission in Vasculitis

• AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

• Companion Diagnostics Expand HER2 Testing in Metastatic Gastroesophageal Cancer

• Companion Diagnostics Expand HER2 Testing in Metastatic Gastroesophageal Cancer

• Rapid Urine Biomarker Panel Supports Better Kidney Transplant Decisions

• Global Urinalysis Market Gowth Driven by Demand for Automated and POC Testing

• New Liquid Biopsy Approach Shows Promise for Detecting Breast Cancer Recurrence

• Blood Test Measures Amyloid Seeding Activity to Detect Alzheimer’s Disease

• Whole-Blood RNA Test Could Improve Breast Cancer Screening in Dense Breasts

• Computational Tool Identifies Central Asthma Genes for Target Discovery

• New Collaboration Expands Point-of-Care Testing Across UK Community Pharmacies

• Blood Test Markers Could Help Identify Older Adults at Risk of Disability

• FDA Clears Roche Blood Test for Alzheimer’s Amyloid Pathology Assessment

• Age-Related Genomic Differences Could Refine Treatment Decisions in Lung Cancer